Estimate Recalculated Nov 8, 2024 09:31PM EST
Alexander J Denner has an estimated net worth of $12.7 Million. This is based on reported shares across multiple companies, which include BIOGEN IDEC INC., IRONWOOD PHARMACEUTICALS INC, Sarissa Capital Acquisition Corp., ENZON PHARMACEUTICALS INC, Iterum Therapeutics plc, ADVENTRX PHARMACEUTICALS INC, APRICUS BIOSCIENCES, INC., Regulus Therapeutics Inc., Bioverativ Inc., Innoviva, Inc., ARIAD PHARMACEUTICALS INC, AMYLIN PHARMACEUTICALS INC, VIVUS INC, MEDICINES CO /DE, and IMCLONE SYSTEMS INC.
Alexander J Denner's CIK is 0001361754
2011 was Alexander J Denner's most active year for acquiring shares with 9 total transactions. Alexander J Denner's most active month to acquire stocks was the month of May. 2013 was Alexander J Denner's most active year for disposing of shares, totalling 13 transactions. Alexander J Denner's most active month to dispose stocks was the month of April. 2013 saw Alexander J Denner paying a total of $2,189,294.25 for 107,538 shares, this is the most they've acquired in one year. In 2013 Alexander J Denner cashed out on 81,850 shares for a total of $9,750,497.35, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!